MARKET

ALKS

ALKS

Alkermes Plc
NASDAQ
30.36
-1.04
-3.31%
After Hours: 30.36 0 0.00% 18:20 05/06 EDT
OPEN
31.02
PREV CLOSE
31.40
HIGH
31.27
LOW
30.18
VOLUME
1.59M
TURNOVER
--
52 WEEK HIGH
36.45
52 WEEK LOW
22.90
MARKET CAP
5.00B
P/E (TTM)
14.44
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Alkermes (ALKS) and Summit Therapeutics (SMMT)
TipRanks · 1d ago
Weekly Report: what happened at ALKS last week (0428-0502)?
Weekly Report · 1d ago
Alkermes First Quarter 2025 Earnings: EPS Beats Expectations
Simply Wall St · 3d ago
Alkermes Price Target Raised to $40.00/Share From $39.00 by RBC Capital
Dow Jones · 4d ago
Alkermes Is Maintained at Sector Perform by RBC Capital
Dow Jones · 4d ago
RBC Capital Maintains Sector Perform on Alkermes, Raises Price Target to $40
Benzinga · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN) and Alkermes (ALKS)
TipRanks · 4d ago
Alkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright
TipRanks · 4d ago
More
About ALKS
More
Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Recently
Symbol
Price
%Change

Webull offers Alkermes Plc stock information, including NASDAQ: ALKS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALKS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALKS stock methods without spending real money on the virtual paper trading platform.